MediWound Ltd. (MDWD) vs Minerva Neurosciences, Inc. (NERV)

A side-by-side comparison of MediWound Ltd. and Minerva Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MDWD vs NERV

growth of $100 · dividends reinvested · last 10y
MDWD -75.0% (-12.9%/yr)NERV -97.0% (-29.7%/yr)MDWD compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020182020202220242026$25$3
MDWD NERV

MDWD vs NERV: by the numbers

  • •MDWD is the larger company ($169M vs $160M market cap).
  • •Both run net losses; NERV's is the smaller (0.00% vs -170.10% net margin).

Metrics side by side

Valuation

MetricMDWDNERV
P/S ratio14.26N/A
P/B ratio4.75N/A

Profitability

MetricMDWDNERV
Gross margin15.46%0.00%
Operating margin-149.06%0.00%
Net margin-170.10%0.00%
ROE-56.61%N/A
ROIC-58.55%-38.56%

Growth (annualized)

MetricMDWDNERV
Revenue CAGR (5Y)-13.99%N/A
Total return CAGR (5Y)-9.04%-22.14%

Frequently asked

How have MDWD and NERV total returns compared?
Over the past 10 years, MDWD delivered -12.86% and NERV delivered -29.77% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.